Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NiSource
NI
$19.5B
| $124M | 0.23% |
6,919,995
-7,185,291
| -51% | -$128M |
|
77
Hilton Worldwide
HLT
$73.5B
| $120M | 0.23% |
1,456,245
+643,880
| +79% | +$56.5M |
|
|
PXD
78
DELISTED
Pioneer Natural Resource Co.
PXD
| $120M | 0.23% |
865,888
+445,537
| +106% | +$70.6M |
|
79
Liberty Global Class A
LBTYA
$3.63B
| $118M | 0.22% |
2,656,264
+1,012,357
| +62% | +$45M |
|
80
Walmart Inc
WMT
$825B
| $116M | 0.22% |
4,914,963
+971,775
| +25% | +$24.8M |
|
81
Danaher
DHR
$154B
| $113M | 0.21% |
1,965,863
-1,632,212
| -45% | -$93.5M |
|
|
HOLX
82
DELISTED
Hologic
HOLX
| $112M | 0.21% |
2,951,214
-1,327,174
| -31% | -$46.5M |
|
83
Canadian Pacific Kansas City
CP
$85B
| $112M | 0.21% |
3,491,975
+2,064,085
| +145% | +$73.7M |
|
84
Patterson-UTI
PTEN
$4.71B
| $109M | 0.21% |
5,774,284
+2,192,610
| +61% | +$45.5M |
|
85
Ventas
VTR
$47.7B
| $108M | 0.21% |
1,530,213
+811,197
| +113% | +$63.4M |
|
|
RKT
86
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $108M | 0.2% |
1,797,254
+1,177,887
| +190% | +$74.4M |
|
87
Kimberly-Clark
KMB
$36.4B
| $108M | 0.2% |
1,020,839
+745,036
| +270% | +$81.1M |
|
|
SRC
88
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $107M | 0.2% |
2,459,468
+1,166,092
| +90% | +$58.2M |
|
89
Zions Bancorporation
ZION
$9.95B
| $106M | 0.2% |
3,325,580
+326,941
| +11% | +$9.62M |
|
90
Diamondback Energy
FANG
$59B
| $103M | 0.2% |
1,371,709
-392,143
| -22% | -$31.2M |
|
91
HCA Healthcare
HCA
$92.9B
| $103M | 0.2% |
1,139,743
+830,144
| +268% | +$66.5M |
|
|
SUNE
92
DELISTED
SUNEDISON, INC COM
SUNE
| $103M | 0.2% |
3,456,933
+2,322,175
| +205% | +$66.1M |
|
93
Molson Coors Class B
TAP
$8.01B
| $103M | 0.19% |
1,468,556
-309,317
| -17% | -$23M |
|
94
Cisco
CSCO
$438B
| $101M | 0.19% |
3,677,040
-1,498,885
| -29% | -$43M |
|
|
FITB
95
Fifth Third Bancorp
FITB
$49.7B
| $101M | 0.19% |
4,838,434
+1,927,477
| +66% | +$39M |
|
96
Southwest Airlines
LUV
$19.8B
| $99.4M | 0.19% |
3,003,647
+201,566
| +7% | +$7.88M |
|
97
Charter Communications
CHTR
$17.9B
| $98.6M | 0.19% |
+575,958
| New | +$104M |
|
98
Illumina
ILMN
$33.1B
| $98.5M | 0.19% |
463,725
-33,219
| -7% | -$6.49M |
|
99
DaVita
DVA
$11.1B
| $98.1M | 0.19% |
1,234,535
+1,047,643
| +561% | +$86M |
|
100
Tenet Healthcare
THC
$22.6B
| $98M | 0.19% |
1,693,684
+1,441,105
| +571% | +$73.6M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.